Sourya Shrestha

Sourya Shrestha

souryashrestha.bsky.social

Infectious disease modeler | tuberculosis | pathogen interaction | global health | 🇳🇵| 🇺🇸

👤 Joined on 13 November 2024

623

Followers

763

Following

31

Total Posts

📜 Kullanıcı Geçmişi

  • 13 Kas 2024, 17:43
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @souryashrestha.bsky.social

🚫 Blokladığı Kullanıcılar

❤️ Beğendiği Gönderiler

3HP implementation is highly cost effective & should be scaled up nationwide to accelerate progress towards END TB goals. #UnionConference @johnshopkinssph.bsky.social @lstmnews.bsky.social (2/3)

Show Post

Our colleague Anchal Thapa presenting at #Unionconference on ‘Impact & cost-effectiveness of implementing TB preventive treatment among adult household contact persons in Nepal: A model-based analysis’. @johnshopkinssph.bsky.social @lstmnews.bsky.social Highlights👇(Thread 1/3)

Show Post

Some notes about TB prevention, as a former TB patient. TB is a bacterial disease. There is a vaccine, but it has variable efficacy & is not widely used in the U.S.. So, you can't make a "personal choice" (vaccine) to maximally protect yourself against this disease. So what protects you?

Show Post

A huge part of teaching epidemiology is teaching how wrong the data could be, and how to make them less wrong (never right, there is always bias)

Show Post

This new guidance is yet another step closer towards an isolationist, diminished view of American science. Changing rules on the fly wastes time & effort and undermines the pipeline of discovery and innovation. Unacceptable & inexcusable (again): grants.nih.gov/grants/guide...

Show Post

Select language

Install App

Install App